Newly initiated opioid treatment and the risk of fall-related injuries: A nationwide, register-based, case-crossover study in Sweden

CNS Drugs

Volumn 27, Issue 2, 2013, Pages 155-161

  Söderberg, Karin C ^a,b   Laflamme, Lucie ^a   Möller, Jette ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CODEINE; DEXTROPROPOXYPHENE; FENTANYL; KETOBEMIDONE; MORPHINE; OPIATE; OXYCODONE; TRAMADOL;

ADULT; AGED; ARTICLE; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG USE; FALL RISK; FALLING; FEMALE; HUMAN; INJURY; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 84876911527     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.1007/s40263-013-0038-1     Document Type: Article

References (44)

1. The National Board of Health and Welfare. Systematiskt arbete för äldres säkerhet, om fall, trafikolyckor och bränder. The National Board of Health and Welfare: Stockholm; 2007.
2. The National Board of Health and Welfare. Indikatorer för god läkemedelsterapi hos äldre. The National Board of Health and Welfare: Stockholm; 2010.
3. The National Board of Health and Welfare. Statistical database of health and medical care (online). http://www.socialstyrelsen.se/statistik/ statistikdatabas. Accessed 17 Apr 2012.
4. Okie S. A flood of opioids, a rising tide of deaths. New Engl J Med. 2010;363(21):1981-5.
5. Walwyn WM, Miotto KA, Evans CJ. Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug Alcohol Depend. 2010;108(3):156-65.
6. Friedrich MJ. Research yields new insights into mechanisms and treatment of pain. JAMA. 2012;307(3):239-41.
7. Lovell SJ, Taira T, Rodriguez E, et al. Comparison of valdecoxib and an oxycodone-acetaminophen combination for acute musculoskeletal pain in the emergency department: a randomized controlled trial. Acad Emerg Med. 2004;11(12):1278-82.
8. Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62(10):1172-81.
9. von Meyer L. Opioids and driving ability (in German). MMW Fortschr Med. 2006;148(18):33-4.
10. Buckeridge D, Huang A, Hanley J, et al. Risk of injury associated with opioid use in older adults. J Am Geriatr Soc. 2010;58(9):1664-70.
11. Coben JH, Davis SM, Furbee PM, et al. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med. 2010;38(5):517-24.
12. Green TC, Grau LE, Carver HW, et al. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. Drug Alcohol Depend. 2011;115(3):221-8.
13. Reith D, Fountain J, Tilyard M. Opioid poisoning deaths in New Zealand (2001-2002). N Z Med J. 2005;118(1209):U1293.
14. Leung SY. Benzodiazepines, opioids and driving: an overview of the experimental research. Drug Alcohol Rev. 2011;30(3):281-6.
15. Kelly KD, Pickett W, Yiannakoulias N, et al. Medication use and falls in community-dwelling older persons. Age Ageing. 2003;32(5):503-9.
16. Baranzini F, Diurni M, Ceccon F, et al. Fall-related injuries in a nursing home setting: is polypharmacy a risk factor? BMC Health Serv Res. 2009;9:228.
17. Kallin K, Gustafson Y, Sandman PO, et al. Drugs and falls in older people in geriatric care settings. Aging Clin Exp Res. 2004;16(4):270-6.
18. Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003;163(8):949-57.
19. Ebly EM, Hogan DB, Fung TS. Potential adverse outcomes of psychotropic and narcotic drug use in Canadian seniors. J Clin Epidemiol. 1997;50(7):857-63.
20. Guo Z, Wills P, Viitanen M, et al. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol. 1998;148(9):887-92.
21. Walker PC, Alrawi A, Mitchell JF, et al. Medication use as a risk factor for falls among hospitalized elderly patients. AJHP. 2005;62(23):2495-9.
22. Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology. 1998;44(4):217-21.
23. Moden B, Merlo J, Ohlsson H, et al. Psychotropic drugs and falling accidents among the elderly: a nested case control study in the whole population of Scania, Sweden. J Epidemiol Comm Health. 2010;64(5):440-6.
24. Moden B, Ohlsson H, Merlo J, et al. Psychotropic drugs and accidents in Scania, Sweden. Eur J Public Health. 2012;22(5):726-32.
25. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med. 2006;260(1):76-87.
26. Shorr RI, Griffin MR, Daugherty JR, et al. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol. 1992;47(4):M111-5.
27. Neutel CI, Hirdes JP, Maxwell CJ, et al. New evidence on benzodiazepine use and falls: the time factor. Age Ageing. 1996;25(4):273-8.
28. McQuay H. Opioids in pain management. Lancet. 1999;353(9171):2229-32.
29. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133(2):144-53.
30. Maclure M, Mittleman MA. Should we use a case-crossover design? Ann Rev Public Health. 2000;21:193-221.
31. Walker AM. Confounding by indication. Epidemiology. 1996;7(4):335-6.
32. Schneeweiss S, Sturmer T, Maclure M. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 1997;6(Suppl. 3):S51-9.
33. Delaney JA, Suissa S. The case-crossover study design in pharmacoepidemiology. Stat Methods Med Res. 2009;18(1):53-65.
34. The National Board of Health and Welfare. The national patient register (NPR) (online). http://www.socialstyrelsen.se/register/halsodataregister/ patientregistret. Accessed 21 May 2012.
35. Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register: opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726-35.
36. WHO Collaborating Centre for Drug Statistics Methodology. The Anatomical Therapeutic Chemical (ATC) classification system, structure and principles (online). http://www.whocc.no/atc/structure-and-principles/. Accessed 17 Apr 2012.
37. Handoko KB, Zwart-van Rijkom JE, Hermens WA, et al. Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study. Pharmacoepidemiol Drug Saf. 2007;16(2):189-96.
38. Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf. 1999;21(2):101-22.
39. Loeber S, Nakovics H, Kniest A, et al. Factors affecting cognitive function of opiate-dependent patients. Drug Alcohol Depend. 2012;120(1-3):81-7.
40. Zacny JP, Gutierrez S. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacology (Berl). 2003;170(3):242-54.
41. Bergstrom MF, Byberg L, Melhus H, et al. Extent and consequences of misclassified injury diagnoses in a national hospital discharge registry. Inj Prev. 2011;17(2):108-13.
42. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
43. Shah ND, Dunlay SM, Ting HH, et al. Long-term medication adherence after myocardial infarction: experience of a community. Am J Med. 2009;122(10):961 e7-13.
44. Morris LS, Schulz RM. Patient compliance: an overview. J Clin Pharm Ther. 1992;17(5):283-95.